SKI Market

Indian Indices

Nifty

25,879.15 3.35
(0.01%)

Sensex

84,160.15 -318.52
( -0.38%)

Bank Nifty

58,381.95 107.30
( 0.18%)

Nifty IT

36,679.50 -175.90
( -0.48%)

Global Indices

Nasdaq

47,468.90 -806.92
(-1.67%)

Dow Jones

6,758.27 -113.65
(-1.65%)

Hang Seng

50,333.56 -948.27
(-1.85%)

Nikkei 225

9,816.37 -95.05
(-0.96%)

Forex

USD-INR

88.59 -0.09
(-0.10%)

EUR-INR

102.60 0.08
(0.08%)

GBP-INR

116.32 -0.42
(-0.36%)

JPY-INR

0.57 0.00
(-0.52%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Jubilant Pharmova Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

530019

INE700A01033

140.8744507

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

JUBLPHARMA

17934.79

EPS(TTM)

Face Value()

Div & Yield %

0.44

Back

Apar Industries standalone net profit rises 42.80% in the September 2025 quarter

Oct 29,2025

Net profit of Apar Industries rose 42.80% to Rs 253.87 crore in the quarter ended September 2025 as against Rs 177.78 crore during the previous quarter ended September 2024. Sales rose 26.70% to Rs 5441.30 crore in the quarter ended September 2025 as against Rs 4294.48 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	5441.30	4294.48	27
OPM %	8.44	7.65	-
PBDT	378.30	268.30	41
PBT	341.67	239.41	43
NP	253.87	177.78	43

25,879.15 3.35 (0.01%)

84,160.15 -318.52 ( -0.38%)

58,381.95 107.30 ( 0.18%)

36,679.50 -175.90 ( -0.48%)

47,468.90 -806.92 (-1.67%)

6,758.27 -113.65 (-1.65%)

50,333.56 -948.27 (-1.85%)

9,816.37 -95.05 (-0.96%)

88.59 -0.09 (-0.10%)

102.60 0.08 (0.08%)

116.32 -0.42 (-0.36%)

0.57 0.00 (-0.52%)